Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
在晚期 ALK 阳性非小细胞肺癌患者中,治疗药物监测指导给药与标准剂量阿来替尼的比较:一项国际多中心 IV 期随机对照试验的研究方案 (ADAPT ALEC)
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1136221
Meertens, Marinda; Muntinghe-Wagenaar, M Benthe; Sikkema, Barend J; Lopez-Yurda, Marta; Retèl, Valesca P; Paats, Marthe S; Ter Heine, Rob; Schuuring, Ed; Timens, Wim; Touw, Daan J; van Boven, Job F M; de Langen, Adrianus J; Hashemi, Sayed M S; Hendriks, Lizza E L; Croes, Sander; van den Heuvel, Michel M; Dingemans, Anne-Marie C; Mathijssen, Ron H J; Smit, Egbert F; Huitema, Alwin D R; Steeghs, Neeltje; van der Wekken, Anthonie J